Skip to main content
. 2022 Sep 26;8(2):127–133. doi: 10.1136/svn-2022-001612

Table 1.

Characteristics of patients who had an IS at baseline grouped by LDL-C levels

Variable LDL-C categories P value
1.80–2.59 (Reference) <1.40 1.40–1.79 2.60–2.99 3.00–4.89 ≥4.90
N 249 333 50 991 67 587 129 870 270 793 29 886
Age, years 66.60 (±12.01) 67.38 (±12.23) 67.48 (±12.07) 65.99 (±11.89) 65.30 (±11.84) 65.20 (±12.02)
Women (%) 85 778 (34.40%) 16 889 (33.12%) 22 133 (32.75%) 47 631 (36.68%) 112 794 (41.65%) 13 435 (44.95%) <0.01
NIHSS 3 (2.6) 3 (2.7) 3 (2.6) 3 (2.6) 3 (2.6) 4 (2.8) <0.01
Current Smoking, n (%) 60 647 (24.32%) 10 668 (20.92%) 15 322 (22.67%) 32 772 (25.23%) 65 923 (24.11%) 5500 (18.40%) <0.01
Alcohol intake, % 59 613 (23.91%) 11 745 (23.03%) 15 922 (23.56%) 31 268 (24.08%) 62 197 (22.97%) 6529 (21.85%) <0.01
Hypertension, % 158 739 (63.67%) 33 117 (64.95%) 44 174 (65.36%) 83 492 (64.29%) 176 779 (65.28%) 18 670 (62.47%) <0.01
Diabetes mellitus, % 50 629 (20.31%) 12 628 (24.77%) 15 261 (22.58%) 26 347 (20.29%) 59 802 (22.08%) 7171 (23.99%) <0.01
Dislipidemia, % 15 600 (6.26%) 3709 (7.27%) 4753 (7.03%) 8304 (6.39%) 25 550 (9.44%) 3897 (13.04%) <0.01
Previous atrial fib/flutter, % 14 923 (5.99%) 4371 (8.57%) 5449 (8.06%) 6031 (4.64%) 10 086 (3.72%) 1137 (3.80%) <0.01
Dual antiplatelet therapy, % 97 860 (39.25%) 17 697 (34.71%) 25 393 (37.57%) 53 069 (40.86%) 109 214 (40.33%) 9658 (32.32%) <0.01
Intravenous thrombolytic therapy, % 15 135 (6.07%) 3099 (6.08%) 3861 (5.71%) 8134 (6.26%) 16 494 (6.09%) 1452 (4.86%) <0.01
SBP, mm Hg 148.76 (±22.55) 144.93 (±22.59) 146.56 (±22.24) 150.73 (±22.84) 152.52 (±23.22) 151.28 (±24.14) <0.01
Body mass index, kg/m2 23.70 (±3.18) 23.55 (±3.17) 23.58 (±3.17) 23.87 (±3.19) 24.04 (±3.24) 24.01 (±3.64) <0.01

LDL-C, low-density lipoprotein cholesterol; NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood pressure.